Zucker Hillside Hospital is running a medical research program studying the effects of various substances. Participants voluntarily consume alcohol and use substances including cannabis, psilocybin, and MDMA while researchers observe and record their reactions, according to CBS News. The hospital, located on the border of Nassau County and Queens, has spaces designed to resemble a bar or living room, where participants can relax, watch TV, have snacks, and use controlled substances under supervision.
The Feinstein Institutes for Medical Research is leading the study to examine both the potential therapeutic effects and risks of these substances. Participants will be tested in recreational scenarios as well as on a driving simulator to assess impairment in a safe, controlled environment. Dr. Nehal Vadhan, director of the neuropsychopharmacology lab, told CBS News that the study aims to observe higher levels of intoxication to better understand how people, including those with disordered use, experience these substances.
As per The New York Post, studies at the lab are designed to identify triggers of substance use and assess both the therapeutic and harmful effects of these substances. This research is particularly relevant for individuals with psychiatric disorders, where treatment approaches could potentially be informed by controlled use of psychedelics. Dr. Nehal Vadhan stated that understanding the direct effects of these substances is necessary to develop treatments for people with psychiatric disorders.
Participants also complete tasks and are monitored for changes in mood, memory, and decision-making. These simulated environments provide a controlled setting for researchers to study physiological and psychological responses. Observations are conducted anonymously through one-way glass and cameras, as reported by The New York Post. Dr. Nehal Vadhan noted that some challenging experiences are necessary to understand and address aspects of psychiatric disorders.
